Home › Kanser sa Gastrointestinal › Massachusetts › Boston

Pag-aaral pangklinika para sa Kanser sa Gastrointestinal sa Boston, MA

Isang pag-aaral para sa Kanser sa Gastrointestinal ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07544589

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Nagre-recruitPhase 3

GSK Investigational Site, Boston
GSK Investigational Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07218926

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Nagre-recruitPhase 2

Dana-Farber Cancer Institute - Oncology Department, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06760819

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3

Brigham and Women's Hospital (BWH), Boston
Dana-Farber Cancer Institute (DFCI), Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06445062

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

Nagre-recruit

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05375643

Resilience and Equity in Aging, Cancer, and Health (REACH)

Nagre-recruit

Dana-Farber Cancer Institute, Boston

Edad 65 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT04674267

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Nagre-recruitPhase 2

Brigham and Women's Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT04899908

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital Cancer Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

BOLSTER: Learning New Skills to Thrive

Nagre-recruit

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06936878

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Nagre-recruitPhase 1/2

Massachusetts General Hospital,, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT07020221

Pag-aaral para sa Kanser sa Gastrointestinal sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.